| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/11/2010 | WO2010016554A1 Cyclic amine compound |
| 02/11/2010 | WO2010016044A1 Treatment of retinal degeneration |
| 02/11/2010 | WO2010016043A1 Treatment of retinal degeneration |
| 02/11/2010 | WO2010015965A2 Methods and compositions for treating neuronal damage and modulating transient receptor potential channels |
| 02/11/2010 | WO2010015870A1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity |
| 02/11/2010 | WO2010015803A1 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
| 02/11/2010 | WO2010015792A1 Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors |
| 02/11/2010 | WO2010015675A1 Process for the preparation of nicotine-based haptens |
| 02/11/2010 | WO2010015626A1 Crystalline forms of a pyridine derivative |
| 02/11/2010 | WO2010015586A2 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 02/11/2010 | WO2010015585A1 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 02/11/2010 | WO2010015583A1 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/11/2010 | WO2010015037A1 Therapeutic methods and compositions |
| 02/11/2010 | WO2010015032A1 Methods of treating and preventing glucose toxicity |
| 02/11/2010 | WO2010015029A1 Compositions and methods for treating psychiatric disorders |
| 02/11/2010 | WO2009157858A8 Use of cyclolignans for the treatment of a hyperactive immune system |
| 02/11/2010 | WO2009152164A3 Smoking cessation kit and method |
| 02/11/2010 | WO2009141532A3 Derivatives of 1,5-diphenyl pyrrole-3-carboxamide, preparation thereof and use of same as cannabinoid cb1 receptor antagonists |
| 02/11/2010 | WO2009092071A3 Amino acid and peptide pro-drugs of phenolic analgesics and uses thereof |
| 02/11/2010 | US20100035994 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/11/2010 | US20100035978 Combination of cannabinoids for the treatment of peripheral neuropathic pain |
| 02/11/2010 | US20100035962 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof |
| 02/11/2010 | US20100035961 Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof |
| 02/11/2010 | US20100035957 Methods for the Use of Inhibitors of Cytosolic Phospholipase A2 |
| 02/11/2010 | US20100035956 Compounds Having CRTH2 Antagonist Activity |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/11/2010 | US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
| 02/11/2010 | US20100035934 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators |
| 02/11/2010 | US20100035931 Tripyridyl carboxamide orexin receptor antagonists |
| 02/11/2010 | US20100035929 Unnatural dispyrin analogues, preparation and uses thereof |
| 02/11/2010 | US20100035928 Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate |
| 02/11/2010 | US20100035927 Medicament for prophylactic and/or therapeutic treatment of alzheimer-type dementia |
| 02/11/2010 | US20100035923 Vr1 vanilloid receptor antagonists with a iononic substructure |
| 02/11/2010 | US20100035918 Imidazolone Compounds and Methods of Making and Using the Same |
| 02/11/2010 | US20100035916 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 02/11/2010 | US20100035914 Azabicyclic compounds as inhibitors of monoamines reuptake |
| 02/11/2010 | US20100035910 Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts |
| 02/11/2010 | US20100035909 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
| 02/11/2010 | US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases |
| 02/11/2010 | US20100035900 6-Arylmethyl-substituted pyrazolopyrimidines |
| 02/11/2010 | US20100035899 5,7-DISUBSTITUTED[1.3]THIAZOLO[4,5-d]PYRIMIDIN-2(3H)-AMINE DERIVATIVES AND THEIR USE IN THERAPY |
| 02/11/2010 | US20100035893 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
| 02/11/2010 | US20100035885 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 02/11/2010 | US20100035883 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 02/11/2010 | US20100035880 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 02/11/2010 | US20100035875 Triazolopyridine jak inhibitor compounds and methods |
| 02/11/2010 | US20100035871 Benzoxazine derivatives and uses thereof |
| 02/11/2010 | US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds |
| 02/11/2010 | US20100035866 Novel substituted-1, 1-dioxo-benzo[1,2,4]thiadiazin-3ones, preparation method thereof, and pharmaceutical composition containing the same |
| 02/11/2010 | US20100035865 Sulfonamides and Pharmaceutical Compositions Thereof |
| 02/11/2010 | US20100035861 Meptazinol Biligand Derivatives and/or their Salts, Preparation Method and Uses Thereof |
| 02/11/2010 | US20100035858 Novel Compositions and Methods for Binding and Inhibiting 5-HT4 Receptor |
| 02/11/2010 | US20100035847 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100035834 Novel 1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof |
| 02/11/2010 | US20100035826 Controlled release of phenolic opioids |
| 02/11/2010 | US20100035820 Amidated dopamine neuron stimulating peptides for cns dopaminergic upregulation |
| 02/11/2010 | US20100035817 Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 02/11/2010 | US20100035811 Phosphoinositide Modulation For The Treatment Of Neurodegenerative Diseases |
| 02/11/2010 | US20100034903 Shinyleaf yellowhorn extract, methods for extraction and uses thereof |
| 02/11/2010 | US20100034895 Methods of treatment using a gastric retained gabapentin dosage |
| 02/11/2010 | US20100034873 Transdermal ricinoleic acid compositions |
| 02/11/2010 | US20100034838 Transdermal Administration of Active Agents for Systemic Effect |
| 02/11/2010 | US20100034823 Crystalline anti-hTNFalpha antibodies |
| 02/11/2010 | US20100034809 Compositions and Methods for Antibodies Targeting Complement Protein C5 |
| 02/11/2010 | US20100034802 Treatment of pain |
| 02/11/2010 | US20100034801 Non-Polymeric Compositions for Controlled Drug Delivery |
| 02/11/2010 | US20100034799 Anti-cocaine compositions and treatment |
| 02/11/2010 | US20100034796 Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction |
| 02/11/2010 | US20100034779 Compositions and methods for producing pluripotent cells from adult testis |
| 02/11/2010 | CA2738866A1 Flupirtine hydrochloride maleic acid cocrystal |
| 02/11/2010 | CA2736353A1 Mesenchymal stromal cell populations and methods of isolating and using same |
| 02/11/2010 | CA2733499A1 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/11/2010 | CA2733432A1 Treatment of autoimmune and inflammatory disease |
| 02/11/2010 | CA2733235A1 Crystalline forms of a pyridine derivative |
| 02/11/2010 | CA2733126A1 Methods of treating cognitive impairment |
| 02/11/2010 | CA2732526A1 Oxazole derivatives useful as inhibitors of faah |
| 02/11/2010 | CA2732131A1 Compositions and methods for treating psychiatric disorders |
| 02/11/2010 | CA2731494A1 Process for the preparation of nicotine-based haptens |
| 02/10/2010 | EP2151448A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof |
| 02/10/2010 | EP2151439A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same |
| 02/10/2010 | EP2151436A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 02/10/2010 | EP2151435A1 Pharmaceutical composition for treatment of alzheimer's disease |
| 02/10/2010 | EP2151241A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative |
| 02/10/2010 | EP2151240A1 Therapeutic or prophylactic agent for dyskinesia |
| 02/10/2010 | EP2151238A1 Diazoxide for the treatment of Friedreich's ataxia |
| 02/10/2010 | EP2151237A1 Pharmaceutical composition combining a non-steroidal anti-inflammatory agent and an anticonvulsant agent |
| 02/10/2010 | EP2151236A1 G-protein-conjugated receptor agonist |
| 02/10/2010 | EP2150563A1 HUMANIZED ANTIBODIES TO Aß(20-42) GLOBULOMER AND USES THEREOF |
| 02/10/2010 | EP2150554A1 Solvent-free crystalline form of naltrexone |
| 02/10/2010 | EP2150552A1 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
| 02/10/2010 | EP2150550A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 02/10/2010 | EP2150543A2 Heterocyclic compounds with affinity to muscarinic receptors |
| 02/10/2010 | EP2150535A2 Pyrazole derivatives as p2x7 modulators |
| 02/10/2010 | EP2150534A1 Isoquinolinone derivatives as nk3 antagonists |
| 02/10/2010 | EP2150530A1 Substituted sulfonamide derivatives |
| 02/10/2010 | EP2150525A1 Naphthyl(ethyl) acetamides |
| 02/10/2010 | EP2150265A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism |
| 02/10/2010 | EP2150253A2 Use of 4-cyclopropylmethoxy-<i>n</i>-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas |